Description

LINAGENTA TAB is an oral antidiabetic medication formulated with Linagliptin 5 mg, a Dipeptidyl Peptidase-4 (DPP-4) inhibitor used in the treatment of Type 2 diabetes mellitus. It is primarily used as monotherapy or in combination with other antidiabetic agents such as metformin, sulfonylureas, or insulin to enhance blood sugar control.

Linagliptin works by increasing the levels of incretin hormones, which help to:

• Stimulate insulin release from the pancreas

• Reduce the secretion of glucagon

• Lower blood glucose levels after meals

Unlike some other oral hypoglycemics, Linagliptin has a low risk of hypoglycemia, is weight-neutral, and is well-tolerated in elderly patients and those with renal impairment.

LINAGENTA TAB is manufactured in WHO-GMP and ISO-certified facilities, ensuring strict adherence to international quality standards. It is exported globally by BLUEPILL EXPRESS, a leading name in pharmaceutical exports across Asia, Africa, Europe, the Middle East, and Latin America.